Stocktoria
CytoDyn Inc. CYDY
CytoDyn Inc. financials (annual)
Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $266,000 | $0 | — | — | — | — |
| Gross profit | — | — | — | — | $213,000 | — | — | — | — | — |
| R&D expense | — | — | $7.2M | $2.6M | $27.0M | $53.4M | $52.6M | $42.5M | $38.2M | $20.2M |
| Operating income | -$38.6M | $9.7M | -$18.1M | -$40.6M | -$145.4M | -$104.6M | -$74.6M | -$55.9M | -$45.9M | -$27.3M |
| Interest expense | — | — | — | — | — | — | $18.2M | $3.3M | $5.9M | $612,767 |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$2.8M | $0 | $0 |
| Net income | -$42.7M | $3.7M | -$49.8M | -$79.8M | -$210.8M | -$176.5M | -$139.9M | -$60.7M | -$50.1M | -$25.8M |
| EPS (diluted) | $-0.03 | $0.00 | $-0.05 | $-0.10 | $-0.31 | $-0.30 | $-0.33 | $-0.23 | — | — |
| Operating cash flow | -$17.3M | -$8.8M | -$11.0M | -$25.1M | -$77.7M | -$117.6M | -$68.8M | -$50.5M | -$29.9M | -$26.7M |
| Free cash flow | — | — | — | — | — | -$117.7M | -$68.8M | -$50.5M | -$29.9M | -$26.7M |
| Cash & equivalents | $11.9M | $11.9M | $3.1M | $2.5M | $4.2M | $33.9M | $14.3M | $2.6M | $1.2M | $1.8M |
| Inventory | — | — | $0 | $0 | — | $93.5M | $19.1M | — | — | — |
| Total assets | $14.0M | $18.0M | $11.1M | $11.3M | $29.2M | $132.1M | $50.5M | $20.9M | $4.9M | $8.1M |
| Total liabilities | $123.7M | $114.1M | $127.9M | $120.8M | $123.6M | $153.1M | $53.0M | $29.8M | $18.1M | $9.2M |
| Shareholders' equity | -$109.7M | -$96.0M | -$116.8M | -$109.5M | -$94.4M | -$21.0M | -$2.5M | -$8.9M | -$13.2M | -$1.1M |
Growth · year-over-year
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | -100.0% | — | — | — | — | — | — |
| Net income growth | -1240.2% | — | — | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-05-31. Facts plus Stocktoria's own computed scores — not investment advice.